Berman Capital Advisors, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$11,000
-38.9%
261
-21.4%
0.00%
-33.3%
Q2 2021$18,000
-25.0%
3320.0%0.00%
-40.0%
Q1 2021$24,000
-14.3%
3320.0%0.01%
-28.6%
Q4 2020$28,000
+40.0%
3320.0%0.01%
+16.7%
Q3 2020$20,000
+100.0%
332
+28.7%
0.01%
+100.0%
Q2 2020$10,000
+900.0%
258
+616.7%
0.00%
Q1 2020$1,000
-66.7%
36
+28.6%
0.00%
-100.0%
Q3 2019$3,000
-40.0%
280.0%0.00%
-50.0%
Q2 2019$5,000
+25.0%
280.0%0.00%
+100.0%
Q1 2019$4,000280.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders